Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 1-year follow-up of the use of hydroxycarbamide and didanosine in HIV infection.

× No keyword cloud information.

9 in total

Review 1. Didanosine: an updated review of its use in HIV infection.

Authors: C M Perry; S Noble
Journal: Drugs Date: 1999-12 Impact factor: 9.546

2. Induction of G1 cycle arrest in T lymphocytes results in increased extracellular levels of beta-chemokines: a strategy to inhibit R5 HIV-1.

Authors: Alonso Heredia; Charles Davis; Anthony Amoroso; Joyelle K Dominique; Nhut Le; Erin Klingebiel; Elise Reardon; Davide Zella; Robert R Redfield
Journal: Proc Natl Acad Sci U S A Date: 2003-03-18 Impact factor: 11.205

3. Chronic myelogenous leukemia in an HIV-infected patient.

Authors: X de la Tribonniere; R Leberre; I Plantier; S Alfandari; C Beuscart; J P Jouet; Y Mouton
Journal: Infection Date: 1998 May-Jun Impact factor: 3.553

Review 4. Pharmacokinetics and pharmacodynamics of hydroxyurea.

Authors: P R Gwilt; W G Tracewell
Journal: Clin Pharmacokinet Date: 1998-05 Impact factor: 6.447

5. Hydroxyurea enhances the activities of didanosine, 9-[2-(phosphonylmethoxy)ethyl]adenine, and 9-[2-(phosphonylmethoxy)propyl]adenine against drug-susceptible and drug-resistant human immunodeficiency virus isolates.

Authors: S Palmer; R W Shafer; T C Merigan
Journal: Antimicrob Agents Chemother Date: 1999-08 Impact factor: 5.191

6. Management of HIV-infected Patients with Multidrug-resistant Virus.

Authors: Julio S.G. Montaner; Marianne Harris
Journal: Curr Infect Dis Rep Date: 2002-06 Impact factor: 3.725

Review 7. Hydroxyurea in the treatment of HIV infection: clinical efficacy and safety concerns.

Authors: Julianna Lisziewicz; Andrea Foli; Mark Wainberg; Franco Lori
Journal: Drug Saf Date: 2003 Impact factor: 5.606

8. Quantification of the relative importance of CTL, B cell, NK cell, and target cell limitation in the control of primary SIV-infection.

Authors: Marjet Elemans; Rodolphe Thiébaut; Amitinder Kaur; Becca Asquith
Journal: PLoS Comput Biol Date: 2011-03-03 Impact factor: 4.475

9. Abacavir, efavirenz, didanosine, with or without hydroxyurea, in HIV-infected adults failing initial nucleoside/protease inhibitor-containing regimens.

Authors: Susan Swindells; Calvin J Cohen; Daniel S Berger; Karen T Tashima; Qiming Liao; Bonnie F Pobiner; Jerry W Snidow; Gary E Pakes; Jaime E Hernandez
Journal: BMC Infect Dis Date: 2005-04-08 Impact factor: 3.090

9 in total